Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Han

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
NEJM Evidence|November 26, 2024
Truncated, Not Forgotten - Handling Left Truncation in Time-to-Event StudiesLarry Han
JAMA Oncology|July 17, 2025
Considerations for Using Clinical Practice Data to Study COVID-19 Vaccines in Patients With CancerLarry Han
NEJM Evidence|February 6, 2024
Breaking Free from the Hazard Ratio: Embracing the Restricted Mean Survival Time in Clinical TrialsLarry Han
Statistics in Medicine|September 5, 2022
Identifying surrogate markers in real-world comparative effectiveness researchLarry Han, Xuan Wang, Tianxi Cai
The American Statistician|April 29, 2024
Sensitivity Analyses of Clinical Trial Designs: Selecting Scenarios and Summarizing Operating CharacteristicsLarry Han, Andrea Arfè, Lorenzo Trippa
Journal of the American Statistical Association|August 26, 2025
Robust Inference for Federated Meta-LearningZijian Guo, Xiudi Li, Larry Han, et al.
Journal of the American Statistical Association|September 2, 2025
Federated Adaptive Causal Estimation (FACE) of Target Treatment EffectsLarry Han, Jue Hou, Kelly Cho, et al.
Proceedings of Machine Learning Research|August 28, 2024
Multi-Source Conformal Inference Under Distribution ShiftYi Liu, Alexander W Levis, Sharon-Lise Normand, et al.
Biometrics|April 15, 2022
Robust approach to combining multiple markers to improve surrogacyXuan Wang, Layla Parast, Larry Han, et al.
The American Journal of Drug and Alcohol Abuse|July 23, 2024
Detecting univariate, bivariate, and overall effects of drug mixtures using Bayesian kernel machine regressionJemar R Bather, Larry Han, Alex S Bennett, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
NEJM Evidence|November 26, 2024
Truncated, Not Forgotten - Handling Left Truncation in Time-to-Event StudiesLarry Han
JAMA Oncology|July 17, 2025
Considerations for Using Clinical Practice Data to Study COVID-19 Vaccines in Patients With CancerLarry Han
NEJM Evidence|February 6, 2024
Breaking Free from the Hazard Ratio: Embracing the Restricted Mean Survival Time in Clinical TrialsLarry Han
Statistics in Medicine|September 5, 2022
Identifying surrogate markers in real-world comparative effectiveness researchLarry Han, Xuan Wang, Tianxi Cai
The American Statistician|April 29, 2024
Sensitivity Analyses of Clinical Trial Designs: Selecting Scenarios and Summarizing Operating CharacteristicsLarry Han, Andrea Arfè, Lorenzo Trippa
Journal of the American Statistical Association|August 26, 2025
Robust Inference for Federated Meta-LearningZijian Guo, Xiudi Li, Larry Han, et al.
Journal of the American Statistical Association|September 2, 2025
Federated Adaptive Causal Estimation (FACE) of Target Treatment EffectsLarry Han, Jue Hou, Kelly Cho, et al.
Proceedings of Machine Learning Research|August 28, 2024
Multi-Source Conformal Inference Under Distribution ShiftYi Liu, Alexander W Levis, Sharon-Lise Normand, et al.
Biometrics|April 15, 2022
Robust approach to combining multiple markers to improve surrogacyXuan Wang, Layla Parast, Larry Han, et al.
The American Journal of Drug and Alcohol Abuse|July 23, 2024
Detecting univariate, bivariate, and overall effects of drug mixtures using Bayesian kernel machine regressionJemar R Bather, Larry Han, Alex S Bennett, et al.
Pageof 5